Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tau PET following acute TBI: Off-target binding to blood products, tauopathy, or both?
Butler T, Chiang GC, Niogi SN, Wang XH, Skudin C, Tanzi E, Wickramasuriya N, Spiegel J, Maloney T, Pahlajani S, Zhou L, Morim S, Rusinek H, Normandin M, Dyke JP, Fung EK, Li Y, Glodzik L, Razlighi QR, Shah SA, de Leon M. Butler T, et al. Among authors: normandin m. Front Neuroimaging. 2022;1:958558. doi: 10.3389/fnimg.2022.958558. Epub 2022 Oct 14. Front Neuroimaging. 2022. PMID: 36876118 Free PMC article.
Novel multi-modal methodology to investigate placebo response in major depressive disorder.
Cusin C, Dillon DG, Belleau E, Normandin MD, Petibon Y, El-Fakri G, Dhaynaut M, Hooker J, Kaptchuk T, McKee M, Hayden E, Meyer A, Jahan A, Origlio J, Ang YS, Brunner D, Kang M, Long Y, Fava M, Pizzagalli DA. Cusin C, et al. Among authors: normandin md. J Affect Disord. 2025 Jan 1;368:1-7. doi: 10.1016/j.jad.2024.08.226. Epub 2024 Sep 2. J Affect Disord. 2025. PMID: 39233242 Clinical Trial.
Selective Mu-Opioid Receptor Imaging Using 18F-Labeled Carfentanils.
Lee SJ, Pearson TD, Dhaynaut M, MacDonagh AC, Wey HY, Wilks MQ, Roth BL, Hooker JM, Normandin MD. Lee SJ, et al. Among authors: normandin md. J Med Chem. 2025 Jan 7. doi: 10.1021/acs.jmedchem.4c02287. Online ahead of print. J Med Chem. 2025. PMID: 39772615
Deciphering the effects of radiopharmaceutical therapy in the tumor microenvironment of prostate cancer: an in-silico exploration with spatial transcriptomics.
Hong J, Bae S, Cavinato L, Seifert R, Ryhiner M, Rominger A, Erlandsson K, Wilks M, Normandin M, El-Fakhri G, Choi H, Shi K. Hong J, et al. Among authors: normandin m. Theranostics. 2024 Oct 28;14(18):7122-7139. doi: 10.7150/thno.99516. eCollection 2024. Theranostics. 2024. PMID: 39629134 Free PMC article.
PET mapping of receptor occupancy using joint direct parametric reconstruction.
Marin T, Belov V, Chemli Y, Ouyang J, Najmaoui Y, Fakhri GE, Duvvuri S, Iredale P, Guehl NJ, Normandin MD, Petibon Y. Marin T, et al. Among authors: normandin md. IEEE Trans Biomed Eng. 2024 Oct 24;PP. doi: 10.1109/TBME.2024.3486191. Online ahead of print. IEEE Trans Biomed Eng. 2024. PMID: 39446540
PET imaging of M4 muscarinic acetylcholine receptors in rhesus macaques using [11C]MK-6884: Quantification with kinetic modeling and receptor occupancy by CVL-231 (emraclidine), a novel positive allosteric modulator.
Belov V, Guehl NJ, Duvvuri S, Iredale P, Moon SH, Dhaynaut M, Chakilam S, MacDonagh AC, Rice PA, Yokell DL, Renger JJ, El Fakhri G, Normandin MD. Belov V, et al. Among authors: normandin md. J Cereb Blood Flow Metab. 2024 Aug;44(8):1329-1342. doi: 10.1177/0271678X241238820. Epub 2024 Mar 13. J Cereb Blood Flow Metab. 2024. PMID: 38477292
138 results